Form D · Other
Vaxxinator Enterprises Inc.
Vancouver, A1 · CIK 0001832042
Offering snapshot reported Nov 10, 2021 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 26, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2021 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Apr 5, 2021 | Initial | $210,000 | No comparison | 4 | SEC filing |
| Feb 22, 2021 | Initial | $125,000 | No comparison | 1 | SEC filing |
| Nov 12, 2020 | Initial | $375,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-420606
The Issuer issued an aggregate of 1,000,000 common shares at a deemed price of USD$3.00 per share as consideration pursuant to a sponsorship agreement.
Source: Form D, filed Nov 10, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Campbell Becher | Director, Executive |
| Olivier Centner | Director, Executive |
| Torsten E. Maehle | Director |
| Brian Meadows | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
Suite 2300, Bentall 5, 550 Burrard Street
Vancouver, A1, V6C 2B5
Vancouver, A1, V6C 2B5